Cellectar Biosciences, Inc. (CLRB)

$2.08 -2.35% $-0.05 Healthcare

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.

$74.57M

Mr. James V. Caruso

12.00

Florham Park, NJ

May 20, 2005

-0.67

$-3.09

2.46

2.54

-15,432.54%

-1.42

-0.02

2.76

266.94

2.46

-118.82%

-1,855.60%

Similar stocks (12)

Longboard Pharmaceuticals, Inc.

LBPH

$30.74 -10.43%
Neutral

Capricor Therapeutics, Inc.

CAPR

$4.41 -3.92%
Downtrend

Benitec Biopharma Inc.

BNTC

$8.42 3.31%
Neutral

Aileron Therapeutics, Inc.

ALRN

$2.79 1.82%
Downtrend

NextCure, Inc.

NXTC

$1.33 -5.00%
Downtrend

Lumos Pharma, Inc.

LUMO

$3.87 -0.51%
Neutral

Bolt Biotherapeutics, Inc.

BOLT

$0.64 3.99%
Downtrend

EOM Pharmaceuticals Holdings, Inc.

IMUC

$0.14 74.68%
Downtrend

Monopar Therapeutics Inc.

MNPR

$4.19 8.55%
Neutral

Tenax Therapeutics, Inc.

TENX

$3.78 -0.79%
Downtrend

Pulmatrix, Inc.

PULM

$2.06 3.52%
Downtrend

Bio-Path Holdings, Inc.

BPTH

$1.00 -2.93%
Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.01993%

$122.64 -0.28%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.10 0.71%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.07 0.71%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.72 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$178.36 0.55%
Uptrend